Skip to main content
. 2022 Sep 18;112(3):640–647. doi: 10.1016/j.xphs.2022.09.014

Fig. 5.

Fig 5

The Comirnaty® development process was accelerated without compromising compliance or safety.

DP, drug product; EUA, Emergency Use Authorization; IVT, in vitro transcription; LNP, lipid nanoparticle; mRNA, messenger RNA; pDNA, plasmid DNA.